Speculations on the Future of Psychiatric Diagnosis

被引:11
作者
Rush, A. John [1 ,2 ,3 ]
Ibrahim, Hisham M. [4 ]
机构
[1] Duke Natl Univ Singapore, Singapore, Singapore
[2] Duke Univ, Dept Psychiat, Sch Med, Durham, NC 27706 USA
[3] Texas Tech Hlth Sci Ctr, Dept Psychiat, Permian Basin, TX USA
[4] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA
关键词
Psychiatric syndrome; biomarkers; psychiatric diagnosis; BIOMARKERS; MANAGEMENT; CANCER;
D O I
10.1097/NMD.0000000000000821
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V), criterion symptom listings are frequently used in clinical practice as checklists to make diagnoses. However, most DSM-V conditions are, in fact, syndromes, that is, collections of signs and symptoms that commonly occur together in the clinic. This report discusses the value of syndromes in medicine and psychiatry. It is argued that a more precise future enumeration of brain circuits and the pathogenesis of psychiatric conditions will help us better understand and treat psychiatric syndromes, but they are unlikely to eliminate the need to categorize psychiatric conditions. We expect that biomarkers will play an increasingly critical role in psychiatric diagnosis. Beyond a better mechanistic understanding of the DSM-V syndromes, future diagnostic efforts will need to increase the focus on function and address risk factors for nonresponse and relapse. We suggest that new artificial intelligence advances will increase the efficiency and acceptability of psychiatric diagnosis and assist with treatment delivery.
引用
收藏
页码:481 / 487
页数:7
相关论文
共 23 条
  • [1] Application of artificial intelligence to the management of urological cancer
    Abbod, Maysam F.
    Catto, James W. F.
    Linkens, Derek A.
    Hamdy, Freddie C.
    [J]. JOURNAL OF UROLOGY, 2007, 178 (04) : 1150 - 1156
  • [2] [Anonymous], 2017, WHO DIS ASS SCH 2 0
  • [3] [Anonymous], BIOM QUAL PROGR
  • [4] [Anonymous], 2017, International Classification of Functioning
  • [5] [Anonymous], FAC FIGHT FAT PRACT
  • [6] [Anonymous], 2001, Origins of Neuroscience: A History of Explorations Into Brain Function
  • [7] MDDScore: Confirmation of a Blood Test to Aid in the Diagnosis of Major Depressive Disorder
    Bilello, John A.
    Thurmond, Linda M.
    Smith, Katie M.
    Pi, Bo
    Rubin, Robert
    Wright, Suzin M.
    Taub, Floyd
    Henry, Michael E.
    Shelton, Richard C.
    Papakostas, George I.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (02) : E199 - E206
  • [8] Biomarkers for the Development of New Medications for Cocaine Dependence
    Bough, Kristopher J.
    Amur, Shashi
    Lao, Guifang
    Hemby, Scott E.
    Tannu, Nilesh S.
    Kampman, Kyle M.
    Schmitz, Joy M.
    Martinez, Diana
    Merchant, Kalpana M.
    Green, Charles
    Sharma, Jyoti
    Dougherty, Anne H.
    Moeller, F. Gerard
    [J]. NEUROPSYCHOPHARMACOLOGY, 2014, 39 (01) : 202 - 219
  • [9] Carter MJ, 2014, THER RECREAT J, V48, P275
  • [10] Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset
    Chan, M. K.
    Krebs, M-O
    Cox, D.
    Guest, P. C.
    Yolken, R. H.
    Rahmoune, H.
    Rothermundt, M.
    Steiner, J.
    Leweke, F. M.
    van Beveren, N. J. M.
    Niebuhr, D. W.
    Weber, N. S.
    Cowan, D. N.
    Suarez-Pinilla, P.
    Crespo-Facorro, B.
    Mam-Lam-Fook, C.
    Bourgin, J.
    Wenstrup, R. J.
    Kaldate, R. R.
    Cooper, J. D.
    Bahn, S.
    [J]. TRANSLATIONAL PSYCHIATRY, 2015, 5 : e601 - e601